<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE TEI.2 SYSTEM "tei_bawe.dtd">
<TEI.2 id="_0194g" n="version 1.0">
<teiHeader>
<fileDesc>
<titleStmt>
<title>No17 MS Mobitz pacemaker</title>
</titleStmt>
<extent/>
<publicationStmt>
<distributor>British Academic Written English (BAWE) corpus</distributor>
<availability>
<p>The British Academic Written English (BAWE) corpus was developed at the Universities of Warwick, Reading and Oxford Brookes, under the directorship of Hilary Nesi and Sheena Gardner (formerly of the Centre for Applied Linguistics [previously called CELTE], Warwick), Paul Thompson (Department of Applied Linguistics, Reading) and Paul Wickens (Westminster Institute of Education, Oxford Brookes), with funding from the ESRC. Subject to the rights of the these institutions in the BAWE corpus, and pursuant to the ESRC agreement, the BAWE corpus is available to researchers for research purposes PROVIDED THAT the following conditions are met:</p>
<p>1. The corpus files are not distributed in either their original form or in modified form.</p>
<p>2. The texts are used for research purposes only; they should not be reproduced in teaching materials.</p>
<p>3. The texts are not reproduced in full for a wider audience/readership, although researchers are free to quote short passages of text (up to 200 running words from any given text).</p>
<p>4. The BAWE corpus developers (contact: BAWE@warwick.ac.uk) are informed of all projects, dissertations, theses, presentations or publications arising from analysis of the corpus.</p>
<p>5. Researchers acknowledge their use of the corpus using the following form of words: "The data in this study come from the British Academic Written English (BAWE) corpus, which was developed at the Universities of Warwick, Reading and Oxford Brookes under the directorship of Hilary Nesi and Sheena Gardner (formerly of the Centre for Applied Linguistics [previously called CELTE], Warwick), Paul Thompson (Department of Applied Linguistics, Reading) and Paul Wickens (Westminster Institute of Education, Oxford Brookes), with funding from the ESRC (RES-000-23-0800)."</p>
</availability>
</publicationStmt>
<notesStmt>
<note resp="British Academic Written English (BAWE) corpus project">deleted: header: student name; footer: page numbers</note>
<note resp="British Academic Written English (BAWE) corpus project">Proforma</note>
</notesStmt>
<sourceDesc>
<p n="level">4</p>
<p n="date">2005-12</p>
<p n="module title">Cardiovascular Block</p>
<p n="module code">unknown</p>
<p n="genre family">Case study</p>
<p n="discipline">Medicine</p>
<p n="disciplinary group">LS</p>
<p n="grade">D</p>
<p n="number of authors">1</p>
<p n="number of words">1950</p>
<p n="number of s-units">102</p>
<p n="number of p">57</p>
<p n="number of tables">0</p>
<p n="number of figures">0</p>
<p n="number of block quotes">0</p>
<p n="number of formulae">0</p>
<p n="number of lists">3</p>
<p n="number of paragraphs formatted like lists">15</p>
<p n="abstract present">no abstract</p>
<p n="average words per s-unit">19.1</p>
<p n="average s-units per p">1.8</p>
<p n="macrotype of assignment">simple assignment</p>
</sourceDesc>
</fileDesc>
<encodingDesc>
<p>TEI P4 (documented in: BAWE.documentation.pdf)</p>
</encodingDesc>
<profileDesc>
<particDesc>
<person>
<p n="gender">f</p>
<p n="year of birth">1974</p>
<p n="first language">English</p>
<p n="education">UKA</p>
<p n="course">Medicine</p>
<p n="student ID">0194</p>
</person>
</particDesc>
</profileDesc>
</teiHeader>
<text>
<front>
<titlePage>
<docTitle>
<titlePart>
<hi rend="bold">PORTFOLIO CASE No:</hi> 17</titlePart>
</docTitle>
<titlePart>Patient Initials<name type="other"/> Hospital Number Keep separate list Age 69 Gender M</titlePart>
<titlePart>Portfolio Case presentation number: Syncope Phase 2 course document objective(s): 7.8 Arrhythmias Has the patient's permission, including for follow up contact by telephone, been sought and recorded in the case notes? Yes</titlePart>
</titlePage>
</front>
<body>
<div1 type="section">
<head>
<hi rend="bold">Referral information</hi> Source of referral and a summary of key information</head>
<p n="p1.57">
<s n="s1.3;p1.57">Mr <name type="other"/> was down from the <name type="other"/> visiting his sister in law on <name type="date"/> who was an inpatient at the <name type="other"/>. </s>
<s n="s2.3;p1.57">He ran to keep the lift open for his wife and sister in law and the next thing he knew he was lying on the hospital foyer floor. </s>
<s n="s3.3;p1.57">He was assessed in A&amp;E and admitted the same afternoon to CCU. </s>
</p>
</div1>
<div1 type="section">
<head>
<hi rend="bold">History</hi> All <hi rend="bold italic">relevant</hi> information gathered from the patient about the presenting illness, co-existing problems, current treatment, significant past medical history and the social and family background. The patient's view of the nature of the problem and their expectations for treatment. </head>
<div2>
<head rend="underlined">Presenting complaint:</head>
<p n="p2.57">
<s n="s1.1;p2.57">Collapse with loss of consciousness </s>
</p>
</div2>
<div2>
<head rend="underlined">History of presenting complaint:</head>
<p n="p3.57">
<s n="s1.8;p3.57">A similar episode happened 6 months ago, he was running for a ferry and 'keeled over'. </s>
<s n="s2.8;p3.57">He thought he had fainted. </s>
<s n="s3.8;p3.57">He came round very quickly, there had been no warning symptoms such as chest pain, palpitations or breathlessness. </s>
<s n="s4.8;p3.57">He recovered quickly afterwards, he had no limb weakness, he did not feel nauseous, had not bit his tongue or been incontinent during the episode. </s>
<s n="s5.8;p3.57">Between these episodes he felt that he had been 'overdoing it' a few times, he could not explain this further. </s>
<s n="s6.8;p3.57">He has not been to his GP regarding this incident. </s>
<s n="s7.8;p3.57">He has never had any episodes of breathlessness, palpitations, chest pain, intermittent claudication, ankle oedema, orthopneoa or PND. He has had episodes of tiredness but nothing significant. </s>
<s n="s8.8;p3.57">No history of headaches or migraines </s>
</p>
</div2>
<div2>
<head rend="underlined">Past medical history:</head>
<p n="p4.57">
<s n="s1.1;p4.57">No history of hypertension, diabetes, MI, CVA, cholesterol, COPD, Asthma, RF </s>
</p>
<list type="simple">
<item>1948 - intersusseption </item>
<item>1982 - cholecystectomy</item>
<item>1988 - knee arthroscopy (right)</item>
<item>1996 - bilateral inguinal herniorrhaphy </item>
<item>1999 - Abdominal abscess and colon cancer (weighed 1kg) </item>
<item>1999 - DVT</item>
<item>2000 - abdominal wall cancer resection (superior segment of rectus abdominis replaced with mesh)</item>
</list>
</div2>
<div2>
<head rend="underlined">Family history:</head>
<p n="p5.57">
<s n="s1.1;p5.57">Mr <name type="other"/>'s mother lived until she was 98; his father died at 67 of a smoking related illness and his sister died at the age of 8 due to haemophilia. </s>
</p>
</div2>
<div2>
<head rend="underlined">Drug history and allergies:</head>
<p n="p6.57">
<s n="s1.1;p6.57">Currently not taking any medications (prescription, herbal, OTC) </s>
</p>
<p n="p7.57">
<s n="s1.1;p7.57">NKDA, allergic to elastoplast and latex </s>
</p>
<list type="bulleted">
<head>
<hi rend="underlined">Medications during admission - <name type="date"/>
</hi>:</head>
<item>Diazepam 10mg PO pre-op</item>
<item>Vancomycin 1g i.v. pre-op</item>
<item>Vancomycin 1g 12 hours post-op</item>
</list>
</div2>
<div2>
<head rend="underlined">Social history:</head>
<p n="p8.57">
<s n="s1.3;p8.57">He is retired engineer, for the last 10 years of his working life he ran a hotel on the island with his wife. </s>
<s n="s2.3;p8.57">He lives with his wife who is fit and well. </s>
<s n="s3.3;p8.57">They have 2 sons and one daughter. </s>
</p>
<p n="p9.57">
<s n="s1.2;p9.57">He has never smoked. </s>
<s n="s2.2;p9.57">He drinks 8 units of alcohol a week. </s>
</p>
</div2>
<div2>
<head rend="underlined">Systems review:</head>
<p n="p10.57">
<s n="s1.1;p10.57">Nil of note on systems review </s>
</p>
</div2>
</div1>
<div1 type="section">
<head>
<hi rend="bold">Analysis of history</hi> The most likely single cause of the presentation, other possible causes and reasons for these choices. The findings to be looked for on physical examination to help decide the cause.</head>
<p n="p11.57">
<s n="s1.1;p11.57">Likely diagnoses include: </s>
</p>
<p rend="bulleted" n="p12.57">
<s n="s1.3;p12.57">Cardiogenic syncope - due to a tachy or brady arrhythmia. </s>
<s n="s2.3;p12.57">It is more likely to be a brady arrhythmia as Mr <name type="other"/> did not have any feelings of palpitations, which is more common in episodes of tachyarrhythmias. </s>
<s n="s3.3;p12.57">The vague awareness throughout the episodes and quick recovery would more likely point towards a cardiac arrhythmia cause. </s>
</p>
<p rend="bulleted" n="p13.57">
<s n="s1.1;p13.57">Vasovagal syncope - this is less likely as the patient did not have any prodrome, which is suggestive of a vasovagal attack. </s>
</p>
<p rend="bulleted" n="p14.57">
<s n="s1.1;p14.57">Neurological causes - such as epilepsy, TIA, CVA are all unlikely as the patient recovered quickly from each episode and there was no residual focal deficits </s>
</p>
<p rend="bulleted" n="p15.57">
<s n="s1.2;p15.57">Vasomotor syncope - due to poor control of the circulation at times of demand (such as running for a lift) is a possibility. </s>
<s n="s2.2;p15.57">However, the patient has not suffered form episode of micturition syncope, which is often a preceding problem, before </s>
</p>
<p rend="bulleted" n="p16.57">
<s n="s1.1;p16.57">Other causes such as poor eyesight, footwear, electrolyte imbalance, sepsis, PE are all very unlikely from the history and can be pretty much ruled out at this point. </s>
</p>
</div1>
<div1 type="section">
<head>
<hi rend="bold">Physical examination</hi> Highlight the findings most relevant to your clinical problem solving by underlining them</head>
<p n="p17.57">
<s n="s1.1;p17.57">A cheerful gentleman sitting comfortably on the bed. </s>
</p>
<p n="p18.57">
<s n="s1.1;p18.57">No clubbing, peripheral cyanosis, tremour, splinter haemorrhages or xanthomata on his hands. </s>
</p>
<list type="simple">
<item>Pulse = 72 bpm and regular, BP = 150/80, 0 <hi rend="sub">2</hi> sats 94% on air, RR = 16, Temp = 36.9 (apyrexial)</item>
</list>
<p n="p19.57">
<s n="s1.2;p19.57">No evidence of jaundice, anaemia, corneal arcus or xanthelasma in his eyes. </s>
<s n="s2.2;p19.57">No central cyanosis, oedema or lymphadenopathy </s>
</p>
<p n="p20.57">
<s n="s1.1;p20.57">JVP was not raised, there were multiple scars on his abdomen indicating the many operations he has had. </s>
</p>
<p n="p21.57">
<s n="s1.1;p21.57">Cardiovascular, respiratory, abdominal and neurological examination were unremarkable </s>
</p>
</div1>
<div1 type="section">
<head>
<hi rend="bold">Analysis of history and examination</hi> Reasons for your choice of the cause of the patient's problem(s) and any other cause that still needs to be considered at this stage</head>
<p n="p22.57">
<s n="s1.2;p22.57">From the history and examination the most likely cause for this presentation is a cardiac cause; therefore, further investigations need to be carried out to look at possible cardiac pathology, such as brady or tachy arrhythmias. </s>
<s n="s2.2;p22.57">Reasons for the arrhythmia could be due to electrolyte imbalance and needs to be checked on blood tests. </s>
</p>
</div1>
<div1 type="section">
<head>
<hi rend="bold">Formulation of the patient's problem(s)</hi> Encapsulate this in physical, psychological and social terms (the triple diagnosis)</head>
<p n="p23.57">
<s n="s1.4;p23.57">The patient feels very fit and well in spite of these two episodes of syncope. </s>
<s n="s2.4;p23.57">He is a very positive man, who feels that he has been 'blessed' after his close shave with death after the discovery of his GI cancer and subsequent remarkable recovery from this. </s>
<s n="s3.4;p23.57">He has a very supportive wife and family, all of which are strong Christians, which adds psychological help, as well as a good social community network. </s>
<s n="s4.4;p23.57">As he mentioned during the interview, his current problem of brady arrhythmia is an easy medical problem to rectify in comparison and coupled with his engineering ability to understand the general principles behind it, he has appeared to have reacted well to this most recent hospital admission. </s>
</p>
</div1>
<div1 type="section">
<head>
<hi rend="bold">Management</hi> Use the framework of RAPRIOP to structure your proposed management. Refer to the guidelines to the writing of portfolio cases for the details of the issues to be addressed under each heading.</head>
<div2>
<head rend="underlined">Investigations</head>
<p n="p24.57">
<s n="s1.1;p24.57">A&amp;E ECG showed 2:1 AV block with LBBB. </s>
</p>
<p n="p25.57">
<s n="s1.1;p25.57">Troponin levels on admission = &lt;0.01 </s>
</p>
<p n="p26.57">
<s n="s1.1;p26.57">CXR = NAD </s>
</p>
<p n="p27.57">
<s n="s1.1;p27.57">Blood results pre-op: </s>
</p>
<p n="p28.57">
<s n="s1.1;p28.57">HGB = 15.4, WBC = 5.72, PLT = 163, Na+ = 143, K+ = 4, Urea = 7, Creatinine = 104 </s>
</p>
<p n="p29.57">
<s n="s1.1;p29.57">
<name type="date"/>: </s>
</p>
<p n="p30.57">
<s n="s1.5;p30.57">DDD pacemaker inserted with vancomycin cover. </s>
<s n="s2.5;p30.57">The patient went into AF during the operation. </s>
<s n="s3.5;p30.57">This meant that the ventricular pacemaker could be properly tested, while the atrial pacemaker could not. </s>
<s n="s4.5;p30.57">Good anatomical positions were achieved with both leads. </s>
<s n="s5.5;p30.57">As the AF was witnessed and the patient has no previous history of AF he was DC cardioverted the same day before any clot formation could occur. </s>
</p>
<p n="p31.57">
<s n="s1.1;p31.57">The DC cardioversion was 150 joules biphasic machine and was successful. </s>
</p>
<p n="p32.57">
<s n="s1.1;p32.57">Plan - to carry out a 12 lead ECG 12 hours post cardioversion pre-discharge. </s>
</p>
</div2>
<div2>
<head rend="underlined">Reassurance and explanation</head>
<p n="p33.57">
<s n="s1.3;p33.57">The reasons for his two episodes of syncope were explained to Mr <name type="other"/> as well as what was needed to be done to rectify the matter. </s>
<s n="s2.3;p33.57">He was given the relevant literature [1] and opportunities to ask any questions. </s>
<s n="s3.3;p33.57">During the insertion of the pacemaker, Mr <name type="other"/> continually spoke with the registrar regarding the procedure. </s>
</p>
</div2>
<div2>
<head rend="underlined">Prescription/medical intervention:</head>
<p n="p34.57">
<s n="s1.2;p34.57">Mr <name type="other"/> was a well man apart from the 2:1 heart block. </s>
<s n="s2.2;p34.57">He needs no long-term medication; during his stay he needed to have specific pre- and post-operative prophylactic antibiotic cover. </s>
</p>
</div2>
<div2>
<head rend="underlined">Observation</head>
<p n="p35.57">
<s n="s1.1;p35.57">Mr <name type="other"/> was kept on the CCU wired to a 24 hour ECG pre- and 24 hours post- pacemaker insertion. </s>
</p>
</div2>
<div2>
<head rend="underlined">Referral and team working</head>
<p n="p36.57">
<s n="s1.1;p36.57">A&amp;E staff, Consultant Cardiologist and team, nurses, HCAs, radiographers, anaesthetist, catheter lab staff, surgical day-unit staff. </s>
</p>
</div2>
<div2>
<head rend="underlined">Advice and prevention</head>
<p n="p37.57">
<s n="s1.3;p37.57">Mr <name type="other"/> was told that he needed to go and check-in with his own GP when he arrived home. </s>
<s n="s2.3;p37.57">He was advised not to drive for one week post pacemaker insertion. </s>
<s n="s3.3;p37.57">A referral letter was sent to his nearest general hospital in <name type="other"/> where he will be followed-up by a cardiology team and his pacemaker will now be routinely checked to ensure it is working to its maximum capabilities. </s>
</p>
</div2>
</div1>
<div1 type="section">
<head>
<hi rend="bold">Outcome</hi> A description of the progress of the patient as far as possible. This should include consideration of further issues to be resolved. Where appropriate you should contact by telephone patients who have been discharged home.</head>
<p n="p38.57">
<s n="s1.1;p38.57">Mr <name type="other"/> was discharged on the <name type="other"/>, 24 hours post cardioversion and pacemaker insertion. </s>
</p>
</div1>
<div1 type="section">
<head>
<hi rend="bold">Evidence based care and issues for research</hi> A brief consideration of the evidence base required for the diagnosis and management of the patient's problem(s)</head>
<p n="p39.57">
<s n="s1.1;p39.57">There is little evidence for cardiac pacemakers for bradyarrhythmias, however, there has been quite a lot of work looking at ICDs for tachyarrhythmias, which will be what this evidence-based section will look at. </s>
</p>
<p n="p40.57">
<s n="s1.3;p40.57">Cardiac resynchronisation with specialised left ventricular leads has been shown to reduce symptoms and improve survival in patients with symptomatic heart failure, systolic dysfunction, and widened QRS complexes [2]. </s>
<s n="s2.3;p40.57">The implantable cardioverter defibrillator has become the standard therapy for protecting patients against sudden cardiac death. </s>
<s n="s3.3;p40.57">There have been two recent trials, Multicenter Automatic Defibrillator Trial II (MADIT II) [3] and the Sudden Cardiac Death Heart Failure Trial (SCD-HEFT) [4]. </s>
</p>
<p n="p41.57">
<s n="s1.1;p41.57">To be continued... </s>
</p>
</div1>
<div1 type="section">
<head>
<hi rend="bold">Commentary</hi> A commentary on issues of epidemiology, psycho-social, health care delivery, ethical issues or disability relevant to the patient and/or problem</head>
<p n="p42.57">
<s n="s1.1;p42.57">There are three different types of second-degree heart block: </s>
</p>
<p rend="bulleted" n="p43.57">
<s n="s1.3;p43.57">Mobitz Type I or Wenckebach phenomenon. </s>
<s n="s2.3;p43.57">This is when there is progressive PR interval prolongation until a P wave fails to conduct. </s>
<s n="s3.3;p43.57">This process then starts again and is due to block in the AV node </s>
</p>
<p rend="bulleted" n="p44.57">
<s n="s1.2;p44.57">Mobitz Type II occurs when a dropped QRS complex is not preceded by progressive PR interval prolongation. </s>
<s n="s2.2;p44.57">This type of block indicates conduction problems at the infranodal level (His bundle) and carries a greater risk of the heart progressing to complete heart block. </s>
</p>
<p rend="bulleted" n="p45.57">
<s n="s1.1;p45.57">2:1 or 3:1 block occurs when every second or third P wave conducts to the ventricles (always in a fixed ratio). [5] </s>
</p>
<p n="p46.57">
<s n="s1.3;p46.57">Permanent pacemakers are implanted in the body subcutaneously in front of the pectoral muscle. </s>
<s n="s2.3;p46.57">They are powered by a solid-state lithium battery, which usually last 5 - 10 years. </s>
<s n="s3.3;p46.57">Pacemakers can be programmed remotely by transmitting electromagnetic signals through the skin to the pacemaker. </s>
</p>
<p n="p47.57">
<s n="s1.1;p47.57">There are three letters to the different pacemakers, each letter indicates a different function/location: </s>
</p>
<p rend="bulleted" n="p48.57">
<s n="s1.1;p48.57">First letter (A/V/D) indicates which chamber it is pacing </s>
</p>
<p rend="bulleted" n="p49.57">
<s n="s1.1;p49.57">Second letter (A/V/D) indicates which chamber it is sensing </s>
</p>
<p rend="bulleted" n="p50.57">
<s n="s1.1;p50.57">Third letter (D/I) indicates whether it is inhibitory or not. </s>
</p>
<p n="p51.57">
<s n="s1.1;p51.57">Therefore, a DDD is a dual chamber (paces atria and ventricle), dual sensing and reacts in two ways (double) - pacing in the same chamber is inhibited by spontaneous atrial and ventricular signals, and ventricular pacing is triggered by spontaneous atrial events [6]. </s>
</p>
<p n="p52.57">
<s n="s1.1;p52.57">There are a number of complications, these are: </s>
</p>
<p rend="bulleted" n="p53.57">
<s n="s1.2;p53.57">Infection. </s>
<s n="s2.2;p53.57">If the pacemaker system is infected, antibiotic treatment is ineffective and the pacemaker often needs to be removed to treat the infection before another pacemaker is inserted. </s>
</p>
<p rend="bulleted" n="p54.57">
<s n="s1.2;p54.57">Erosion. </s>
<s n="s2.2;p54.57">The pacemaker can erode through the skin, due to a low-grade infection and/or mechanical factors. </s>
</p>
<p rend="bulleted" n="p55.57">
<s n="s1.3;p55.57">Pocket haematoma. </s>
<s n="s2.3;p55.57">Bleeding into the pacemaker pocket may result in significant pain, swelling and can cause wound breakdown. </s>
<s n="s3.3;p55.57">Warfarin is stopped prior to implantation and INR needs to be less than1.5. </s>
</p>
<p rend="bulleted" n="p56.57">
<s n="s1.2;p56.57">Lead displacement. </s>
<s n="s2.2;p56.57">Often an early complication, a CXR is taken prior to discharge to check the placement of the lead [7]. </s>
</p>
</div1>
<div1 type="section">
<head>
<hi rend="bold">Impact on your learning</hi> Describe what you have learnt from this case</head>
<p n="p57.57">
<s n="s1.5;p57.57">Brady arrthymias, what to look for on history and examination. </s>
<s n="s2.5;p57.57">What investigations to carry out and why. </s>
<s n="s3.5;p57.57">Different kinds of heart block. </s>
<s n="s4.5;p57.57">Different pace makers and watching the pacemaker being inserted. </s>
<s n="s5.5;p57.57">Reasons for cardioversion, what needs to be done pre-cardioversion, witnessing two being carried out and knowing when on the ECG the heart should be cardioverted. </s>
</p>
</div1>
</body>
<back>
<div1 type="bibliography">
<head>
<hi rend="underlined">References</hi> :</head>
<p>British heart Foundation. Pacemakers, Heart Information series Number 15. March 2004.</p>
<p>Kusumoto F, Goldschlager NBeyond heart rhythms: new directions for implantable devices. J Interv Card Electrophysiol. 2005 Oct;14(1):5 - 7</p>
<p>Multicenter Automatic Defibrillator Trial II (MADIT II)</p>
<p>Sudden Cardiac Death Heart Failure Trial (SCD-HEFT)</p>
<p>Julian D G, Cowan J C, McLenachan J M. Cardiology. Eighth Ed. Elsevier Saunders, 2005:105</p>
<p>Kumar P, Clark MClinical Medicine.5<hi rend="sup">th</hi> Ed. WB Saunders, 2002</p>
<p>Gray H H, Dawkins K D, Morgan J M <hi rend="italic">et al</hi>., Lecture notes on cardiology. Fourth Ed. Blackwell Publishing 2002:100</p>
</div1>
</back>
</text>
</TEI.2>
